1. Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease. Issue 10 (10th July 2014) Authors: Borgohain, Rupam; Szasz, Jozsef; Stanzione, Paolo; Meshram, Chandrashekhar; Bhatt, Mohit H.; Chirilineau, Dana; Stocchi, Fabrizio; Lucini, Valentina; Giuliani, Rodolfo; Forrest, Emma; Rice, Patricia; Anand, Ravi; the Study 018 Investigators Journal: Movement disorders Issue: Volume 29:Issue 10(2014) Page Start: 1273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease. Issue 10 (10th July 2014) Authors: Borgohain, Rupam; Szasz, Jozsef; Stanzione, Paolo; Meshram, Chandrashekhar; Bhatt, Mohit H.; Chirilineau, Dana; Stocchi, Fabrizio; Lucini, Valentina; Giuliani, Rodolfo; Forrest, Emma; Rice, Patricia; Anand, Ravi Journal: Movement disorders Issue: Volume 29:Issue 10(2014) Page Start: 1273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗